Albert Einstein College of Medicine is a research-intensive medical school located in the Morris Park neighborhood of the Bronx in New York City.

During the past decade, Albert Einstein College of Medicine conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 47 clinical trials were completed, i.e. on average, 63.5% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 29 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albert Einstein College of Medicine" #1 sponsor was "Albert Einstein College of Medicine" with 76 trials, followed by "National Cancer Institute (NCI)" with 18 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Icahn School of Medicine at Mount Sinai" with 3 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albert Einstein College of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 14 trials as a collaborator, "Albert Einstein College of Medicine" with 11 trials as a collaborator, "National Institutes of Health (NIH)" with 10 trials as a collaborator and "National Institute on Aging (NIA)" with 6 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "Albert Einstein College of Medicine" are "HIV Infections" (11 trials), "Breast Cancer" (7 trials), "Dementia" (6 trials), "HIV" (6 trials) and "Stage IIIB Breast Cancer" (6 trials). Many other conditions were trialed in "Albert Einstein College of Medicine" in a lesser frequency.

Most popular intervention types in "Albert Einstein College of Medicine" are "Drug" (115 trials), "Other" (46 trials), "Behavioral" (29 trials), "Biological" (15 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Placebo" (17 trials), "Paclitaxel" (7 trials), "Quality-of-Life Assessment" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Albert Einstein College of Medicine" are 149 trials for "All" genders, 29 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 38 active trials in "Albert Einstein College of Medicine". 1 are not yet recruiting, 19 are recruiting, 15 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 98 completed trials in Albert Einstein College of Medicine, 2 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Albert Einstein College of Medicine, 26 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 56 trials that are defined as “Not Applicable".

Albert Einstein College of Medicine has several departments that took part in Clinical trials: "Albert Einstein Comprehensive Cancer Center" - 198 trials, "Albert Einstein College of Medicine Division of Substance Abuse" - 4 trials, "Vilma Gabbay, MD, MS" - 2 trials